Chirag C Sheth

Dr. Chirag C Sheth

orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2011 in Infection and Immunity
Verified
Journal Article
Open access
Héctor Mora-MontesHéctor Mora-Montes
Héctor Mora-Montes
MNMihai G. Netea
Mihai G. Netea
GFGerben Ferwerda
Gerben Ferwerda
MLMegan D. Lenardon
Megan D. Lenardon
GBGordon D. Brown
Gordon D. Brown
NGNeil Gow
Neil Gow
Chitin is a skeletal cell wall polysaccharide of the inner cell wall of fungal pathogens. As yet, little about its role during fungus-host immune cell interactions is known. We show here that ultrapurified chitin fromCandida albicanscell walls did not stimulate cytokine production directly but blocked the recognition ofC. albicansby human peripheral blood mononuclear cells (PBMCs) and murine macrophages, leading to significant reductions in cytokine production. Chitin did not affect the induction of cytokines stimulated by bacterial cells or lipopolysaccharide (LPS), indicating that blocking was not due to steric masking of specific receptors. Toll-like receptor 2 (TLR2), TLR4, and Mincle (the macrophage-inducible C-type lectin) were not required for interactions with chitin. Dectin-1 was required for immune blocking but did not bind chitin directly. Cytokine stimulation was significantly reduced upon stimulation of PBMCs with heat-killed chitin-deficientC. albicanscells but not with live cells. Therefore, chitin is normally not exposed to cells of the innate immune system but is capable of influencing immune recognition by blocking dectin-1-mediated engagement with fungal cell walls.

1 February 2016 in Postharvest Biology and Technology
Verified
Journal Article
Closed access
ESElena Sanchís
Elena Sanchís
SGSara González
Sara González
CGChristian Ghidelli
Christian Ghidelli
CSChirag C Sheth
Chirag C Sheth
MMMilagros Mateos
Milagros Mateos
María B. Pérez-GagoMaría B. Pérez-Gago
María B. Pérez-Gago

29 January 2021 in Mini-Reviews in Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
HHHsuan Hsu
Hsuan Hsu
CSChirag C Sheth
Chirag C Sheth
VVVeronica Veses
Veronica Veses
In the era of antimicrobial resistance, fungal pathogens are not an exception. Several strategies, including antimicrobial stewardship programs and high throughput screening of new drugs, are being implemented. Several recent studies have demonstrated the effectiveness of plant compounds with antifungal activity. In this systematic review, we examine the use of natural compounds as a possible avenue to fight fungal infections produced by Candida albicans, the most common human fungal pathogen. Electronic literature searches were conducted through PubMed/MEDLINE, Cochrane, and Science Direct limited to the 5 years. A total of 131 articles were included, with 186 plants extracts evaluated. Although the majority of the natural extracts exhibited antifungal activities against C. albicans (both in vivo and in vitro), the strongest antifungal activity was obtained from Lawsonia inermis, Pelargonium graveolens, Camellia sinensis, Mentha piperita, and Citrus latifolia. The main components with proven antifungal activities were phenolic compounds such as gallic acid, thymol, and flavonoids (especially catechin), polyphenols such as tannins, terpenoids and saponins. The incorporation of nanotechnology greatly enhances the antifungal properties of these natural compounds. Further research is needed to fully characterize the composition of all herbal extracts with antifungal activity as well as the mechanisms of action of the active compounds.

21 March 2016 in Journal of the Science of Food and Agriculture
Verified
Journal Article
Closed access
PDF file
ESElena Sanchís
Elena Sanchís
CGChristian Ghidelli
Christian Ghidelli
CSChirag C Sheth
Chirag C Sheth
MMMilagros Mateos
Milagros Mateos
Lluís PalouLluís Palou
Lluís Palou
María B. Pérez-GagoMaría B. Pérez-Gago
María B. Pérez-Gago

25 August 2016 in Letters in Applied Microbiology
Verified
Journal Article
Closed access
PDF file
CSChirag C Sheth
Chirag C Sheth
KMKamilah Makda
Kamilah Makda
ZDZaahid Dilmahomed
Zaahid Dilmahomed
RGRaquel Gonzalez
Raquel Gonzalez
ALArlinda Luzi Luzi
Arlinda Luzi Luzi
VVVeronica Veses
Veronica Veses

19 October 2018 in Journal of Oral Pathology & Medicine
Verified
Journal Article
Open access
PDF file
FGFariah I. Gaba
Fariah I. Gaba
CSChirag C Sheth
Chirag C Sheth
VVVeronica Veses
Veronica Veses
Background More than 90% of malignant tumors of the head and neck are oral squamous cell carcinomas. Early detection of oral squamous cell carcinoma using salivary biomarkers could prevent malignant transformations and enhance patient survival. Methods A systematic search in MEDLINE and the Central Register of Controlled Trials and meta‐analysis were undertaken to identify the screening potential of six salivary biomarkers for early oral squamous cell carcinoma detection: interleukins IL‐8 and IL1‐β, DUSP‐1 and S100P messenger RNAs, and miR125a and miR200a microRNAs. Results The sensitivities of IL‐8 (0.41; 95%CI 0.19‐0.99), IL1‐β (0.26; 95%CI 0.19‐0.99), DUSP‐1 (0.61; 95%CI 0.01‐0.98), and S100P (0.67; 95%CI 0.32‐0.99) were calculated. Specificities of the biomarkers analyzed were found to be IL‐8 (0.69; 95%CI 0.66‐0.99), IL1‐β (0.47; 95%CI 0.46 ‐ 0.90), DUSP‐1 (0.75; 95%CI 0.33‐1) and S100P (0.73; 95%CI 0.18‐0.99). Conclusions Early detection of oral squamous cell carcinoma was best achieved by screening for salivary messenger RNA DUSP‐1 and S100P. Further investigation is required into miRNAs as novel biomarkers.